logo.png
CAR T-Cell Therapy Market Size Expected to Reach USD 107.92 Billion by 2033
July 01, 2024 11:00 ET | Precedence Research
Ottawa, July 01, 2024 (GLOBE NEWSWIRE) -- The global CAR T-cell therapy market size is predicted to increase from USD 8.44 billion in 2023 to approximately USD 107.92 billion by 2033, According to...
cargo-logo-full-color-rgb-1165px@300ppi.jpg
CARGO Therapeutics Announces Appointment of Ginna Laport, MD, as Chief Medical Officer
October 17, 2023 09:05 ET | CARGO Therapeutics, Inc.
— Accomplished clinical leader with significant expertise in hematology/oncology drug development and a track record of advancing multiple modalities of cancer therapeutics — SAN MATEO, Calif., Oct. ...
cargo-logo-full-color-rgb-1165px@300ppi.jpg
CARGO Therapeutics Announces Appointment of Michael Ports, PhD, as Chief Scientific Officer
September 12, 2023 09:05 ET | CARGO Therapeutics, Inc.
– Scientific leader with multi-company cell therapy drug development experience spanning early discovery initiatives through late-stage development – SAN MATEO, Calif., Sept. 12, 2023 (GLOBE...
cargo-logo-full-color-rgb-1165px@300ppi.jpg
CARGO Therapeutics Appoints Biotech Life Sciences Leaders to Board of Directors
August 24, 2023 09:05 ET | CARGO Therapeutics, Inc.
– Board of Director appointments follow the Company’s recent launch and $200 million Series A financing in March 2023 – – Appointments include industry veterans John Orwin as Chairman, David Lubner...
Contrive Datum Insights_Logo.jpg
CAR T-cell Therapy Market Is Expected to Reach USD 6.1 Billion by 2030, Grow at a CAGR Of 13.5% during Forecast Period 2023 To 2030 | Data By Contrive Datum Insights Pvt Ltd.
March 30, 2023 00:00 ET | Contrive Datum Insights Pvt Ltd
Farmington, March 30, 2023 (GLOBE NEWSWIRE) -- The global CAR T-Cell Therapy Market Was Valued at USD 1.7 Billion In 2022, And Is Projected to Reach USD 6.1 Billion By 2030, growing at a CAGR Of...
Future Market Insights.png
Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market to reach US$ 6.82 Billion by 2033, expanding at a CAGR of 6.9%: Future Market Insights, Inc. DUBAI, United Arab Emirates, March 27, 2023 (GLOBE NEWSWIRE) -- During the forecast period 2023 to 2033, the Chimeric Antigen Receptor (CAR) T-Cell Therapy Market is expected to grow at a value of...
logo.png
CAR T-Cell Therapy Market Size to Expand USD 6.43 Bn by 2032
January 17, 2023 09:51 ET | Precedence Research
Ottawa, Jan. 17, 2023 (GLOBE NEWSWIRE) -- The global CAR T-cell therapy market size was valued at USD 2.19 billion in 2022. CAR-T therapy is rapidly expanding due to an increase in cancer cases. For...
AMR Logo.png
CAR T-Cell Therapy Market Predicted to Reach USD 6.1 Billion by 2030 at 13.5% CAGR: Allied Market Research
September 05, 2022 08:56 ET | Allied Market Research
Portland, OR, Sept. 05, 2022 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “CAR T-Cell Therapy Market by Drug type (Axicabtagene Ciloleucel, Tisagenlecleucel, Brexucabtagene...
Certara Logo White Background.png
Certara Announces Collaboration with Leading Cancer Center to Advance CAR T-cell Therapies
July 28, 2022 08:00 ET | Certara
PRINCETON, N.J., July 28, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced a 2-year collaboration with Memorial Sloan Kettering Cancer Center...
NEW LEADING-EDGE TRE
NEW LEADING-EDGE TREATMENT FOR LEUKEMIA NOW OFFERED AT NICKLAUS CHILDREN'S HOSPITAL
June 10, 2021 09:54 ET | Nicklaus Children's Hospital
MIAMI, June 10, 2021 (GLOBE NEWSWIRE) -- Nicklaus Children's Hospital is one of only a few pediatric hospitals in Florida, and the only one in South Florida, to offer the latest immune cell...